Anthropic Launches Project Glasswing: Pioneering AI-Driven Cybersecurity

by THEFUTURE.TEAM

April 13, 2026

Anthropic introduced Project Glasswing, a program that gives selected partners early access to its Claude Mythos Preview model, designed to detect software vulnerabilities. The initiative includes collaborations with companies such as Amazon, Microsoft, and Apple as concerns over AI-driven cyber threats increase.

Innovative Cybersecurity Model

Project Glasswing provides partners with access to an AI model designed to identify vulnerabilities across operating systems, web browsers, and other software. Early testing identified thousands of security issues, according to the company. The model focuses on detecting weaknesses before exploitation, reflecting increased use of AI tools in cybersecurity workflows.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Industry Collaborations And Strategic Impact

The program includes partnerships with cybersecurity and technology companies such as CrowdStrike, Palo Alto Networks, Google, and Nvidia. Participating firms are expected to integrate the model into existing security operations. The launch follows increased attention to AI-related cyber risks, which were widely discussed at recent industry events including the RSA Conference in San Francisco.

Strengthening Industry Standards

Anthropic said it will share findings with industry participants and provide access to more than 40 organizations managing critical software infrastructure. The company also allocated up to $100 million in usage credits and $4 million in funding for open-source security projects. These measures aim to expand collaboration between private companies and open-source communities in vulnerability detection.

Government Engagement And Future Prospects

Anthropic is in discussions with the U.S. government regarding the capabilities of its AI model and its role in national cybersecurity. The initiative follows previous incidents in which vulnerabilities in AI systems were exploited, affecting multiple organizations. Surveys by IBM and Palo Alto Networks indicate that a significant share of executives have already encountered AI-related cyber incidents, reflecting growing adoption and associated risks.

The Future Forbes Realty Global Properties

Colossal Biosciences Seeks Funding At Up To $30 Billion Valuation

by THEFUTURE.TEAM

July 22, 2026

Colossal Biosciences, the biotechnology startup known for its efforts to revive extinct species including the woolly mammoth and dire wolf, is in talks to raise funding at a valuation of $20 billion to $30 billion, according to Axios.

The company was last valued at $10.2 billion in a January funding round. It has since begun generating revenue, Axios reported, although neither the size of the new financing nor its potential investors have been disclosed.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Business Extends Beyond De-Extinction

While Colossal has attracted global attention for its de-extinction projects, the company is also building a broader biotechnology business around the tools developed through that research.

Co-founder and Chief Executive Ben Lamm has said Colossal expects revenue from three areas: conservation technologies, new businesses created from its research and future commercial applications of technologies developed alongside its de-extinction programme.

Expanding Commercial Portfolio

Colossal has already supplied conservation technology to the U.S. government and the United Arab Emirates, which recently invested $60 million in the company, according to Wired.

Its research has also led to the creation of several startups, including plastics recycling company Breaking, computational biology platform Form Bio, which raised $30 million, and AI-driven biology company Astromech, which was valued at $2 billion in March.

Research Continues To Expand

Operating from a 55,000-square-foot facility in Dallas, Colossal continues to broaden its research portfolio.

In April, the company added the bluebuck antelope as its sixth de-extinction target. More recently, the Colossal Foundation partnered with the University of Tasmania to develop vaccines and gene-editing approaches aimed at protecting Tasmanian devils from a contagious facial cancer.

Lamm has also said the company plans to spin out its artificial womb technology, which could eventually have applications in fertility treatment. Speaking to Rolling Stone in May, he said the technology could be ready next year.

Investor Interest In Deep Tech

The fundraising discussions come as investors increase spending on sectors such as biotechnology, longevity and other deep-tech fields.

Lamm has also said Colossal could eventually generate revenue from biodiversity credits if restored species are successfully reintroduced into their natural habitats, creating another potential commercial opportunity.

Breaking news